Isis Pharmaceuticals (ISIS)

21.08 +0.27  +1.30%  May 22, 1:32PM
Add to Watchlists Create an Alert

Isis Pharmaceuticals Shareholders Equity:

201.09M for March 31, 2013
View Full Chart

Isis Pharmaceuticals Shareholders Equity Chart

    Isis Pharmaceuticals Historical Shareholders Equity Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 201.09M
    Dec. 31, 2012 182.77M
    Sept. 30, 2012 170.28M
    June 30, 2012 154.31M
    March 31, 2012 150.87M
    Dec. 31, 2011 171.43M
    Sept. 30, 2011 186.82M
    June 30, 2011 212.22M
    March 31, 2011 227.70M
    Dec. 31, 2010 244.54M
    Sept. 30, 2010 253.71M
    June 30, 2010 262.23M
    March 31, 2010 284.44M
    Dec. 31, 2009 291.72M
    Sept. 30, 2009 293.00M
    June 30, 2009 292.85M
    March 31, 2009 288.85M
    Dec. 31, 2008 67.09M
    Sept. 30, 2008 68.08M
    June 30, 2008 59.02M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Shareholders' Equity

    Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
    Learn More

    Get data for

    ISIS Shareholders Equity Benchmarks

    Companies
    Aegerion Pharmaceuticals 126.76M
    Sanofi
    Biogen Idec 7.339B

    ISIS Shareholders Equity Rankings

    Overall 66th percentile
    2666 of 8005
    Sector 72nd percentile
    188 of 686 in Healthcare
    Industry 86th percentile
    33 of 248 in Biotechnology

    ISIS Shareholders Equity Range, Past 5 Years

    Minimum 59.02M Jun 2008
    Maximum 293.00M Sep 2009
    Average 203.15M